MarketScreener Editorial Features Genmab A/S
Equities
GMAB
DK0010272202
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,583.50 DKK | +3.90% |
|
-7.07% | -21.88% |
| 03/06 | Nordic Equities in North America - Ericsson Gains 0.7 Percent | FW |
| 02/06 | U.S. Futures Slip, European Stocks Edge Up | DJ |
MarketScreener Editorial Features
Search
 | Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight | May 04, 2026 at 02:51 pm IST |
| Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight | May 04, 2026 at 02:48 pm IST |
 | Genmab: From now on, courage to the most patient | April 01, 2025 at 08:27 pm IST |
 | New entries in MarketScreener's Europe portfolio | August 05, 2024 at 02:17 pm IST |
 | New entries in MarketScreener's Europe portfolio | December 08, 2023 at 04:32 pm IST |
 | Analyst recommendations: Charter Communications, Chevron, Match Group, Shopify, Spotify... | May 02, 2022 at 05:32 pm IST |
No results for this search
Filters
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition